# FDA Inspection 1042325 - Biomat USA Inc - February 16, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/fc9a5f94-6e30-41e0-99aa-f3fe57331794/
Source feed: FDA_Inspections

> FDA Inspection 1042325 for Biomat USA Inc on February 16, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042325
- Company Name: Biomat USA Inc
- Inspection Date: 2018-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284418 - 2026-04-02](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/74f3a74f-0489-4fc2-af02-39d40a466c6f/)
- [FDA Inspection 1306756 - 2026-03-05](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/58074812-4fde-4319-9fe8-cd34eae9a713/)
- [FDA Inspection 1307074 - 2026-02-25](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/b16a672f-81c3-4407-8e1f-58ed5b884d24/)
- [FDA Inspection 1303390 - 2026-02-12](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/7a1929b1-9cb7-4c5e-87f0-275c3d9cd5e8/)
- [FDA Inspection 1302478 - 2026-02-05](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/1c393fc3-1877-4c59-a374-2a37cd657c3a/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/3aeaac2d-a7fb-46ea-9b63-c05a6090e244

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d